RELMADA THERAPEUTICS, INC. Operating Income
RELMADA THERAPEUTICS, INC. (RLMD) reported Operating Income of -$15.01 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Income Statement
us-gaap:OperatingIncomeLoss · last filed 2026-08-06
- RELMADA THERAPEUTICS, INC. operating income (loss) for the quarter ending 2026-06-30 was -$15.01M.
- RELMADA THERAPEUTICS, INC. operating income (loss) for the quarter ending 2026-03-31 was -$19.46M.
- RELMADA THERAPEUTICS, INC. operating income (loss) for the quarter ending 2025-12-31 was -$20.33M.
- RELMADA THERAPEUTICS, INC. operating income (loss) for the quarter ending 2025-09-30 was -$10.33M.
- RELMADA THERAPEUTICS, INC. operating income (loss) for fiscal 2025 was -$59.10M.
- RELMADA THERAPEUTICS, INC. operating income (loss) for fiscal 2024 was -$83.89M.
- RELMADA THERAPEUTICS, INC. operating income (loss) for fiscal 2023 was -$103.70M.
- RELMADA THERAPEUTICS, INC. operating income (loss) for fiscal 2022 was -$161.25M.
| Period end | Operating Income (Loss) 3 month | Operating Income (Loss) 3 month as first filed | Operating Income (Loss) 6 month | Operating Income (Loss) 9 month | Operating Income (Loss) 9 month as first filed | Operating Income (Loss) 12 month | Operating Income (Loss) 21 month | Operating Income (Loss) 24 month | Operating Income (Loss) 27 month | Operating Income (Loss) 30 month | Operating Income (Loss) 33 month | Operating Income (Loss) 115 month | Operating Income (Loss) 118 month |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | -$15.01M 10-Q · filed 2026-08-06 | -$34.47M 10-Q · filed 2026-08-06 | -$54.81M derived: sum of 3 quarters · filed 2026-08-06 | -$65.13M derived: sum of 4 quarters · filed 2026-08-06 | |||||||||
| 2026-03-31 | -$19.46M 10-Q · filed 2026-05-12 | -$39.79M derived: sum of 2 quarters · filed 2026-05-12 | -$50.12M derived: sum of 3 quarters · filed 2026-05-12 | -$60.34M derived: sum of 4 quarters · filed 2026-08-06 | |||||||||
| 2025-12-31 | -$20.33M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-19 | -$30.66M derived: sum of 2 quarters · filed 2026-03-19 | -$40.88M derived: sum of 3 quarters · filed 2026-08-06 | -$59.10M 10-K · filed 2026-03-19 | |||||||||
| 2025-09-30 | -$10.33M 10-Q · filed 2025-11-13 | -$20.55M derived: sum of 2 quarters · filed 2026-08-06 | -$38.77M 10-Q · filed 2025-11-13 | -$57.84M derived: sum of 4 quarters · filed 2026-08-06 | |||||||||
| 2025-06-30 | -$10.22M 10-Q · filed 2026-08-06 | -$28.44M 10-Q · filed 2026-08-06 | -$47.52M derived: sum of 3 quarters · filed 2026-08-06 | -$70.52M derived: sum of 4 quarters · filed 2026-08-06 | |||||||||
| 2025-03-31 | -$18.22M 10-Q · filed 2026-05-12 | -$37.29M derived: sum of 2 quarters · filed 2026-05-12 | -$60.30M derived: sum of 3 quarters · filed 2026-05-12 | -$79.12M derived: sum of 4 quarters · filed 2026-05-12 | |||||||||
| 2024-12-31 | -$19.08M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-19 | -$42.08M derived: sum of 2 quarters · filed 2026-03-19 | -$60.90M derived: sum of 3 quarters · filed 2026-03-19 | -$83.89M 10-K · filed 2026-03-19 | |||||||||
| 2024-09-30 | -$23.01M 10-Q · filed 2025-11-13 | -$41.83M derived: sum of 2 quarters · filed 2025-11-13 | -$64.82M 10-Q · filed 2025-11-13 | -$91.64M derived: sum of 4 quarters · filed 2025-11-13 | |||||||||
| 2024-06-30 | -$18.82M 10-Q · filed 2025-08-07 | -$41.81M 10-Q · filed 2025-08-07 | -$68.64M derived: sum of 3 quarters · filed 2025-08-07 | -$91.33M derived: sum of 4 quarters · filed 2025-08-07 | |||||||||
| 2024-03-31 | -$22.99M 10-Q · filed 2025-05-12 | -$49.82M derived: sum of 2 quarters · filed 2025-05-12 | -$72.51M derived: sum of 3 quarters · filed 2025-05-12 | -$98.54M derived: sum of 4 quarters · filed 2025-05-12 | |||||||||
| 2023-12-31 | -$26.83M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-27 | -$49.52M derived: sum of 2 quarters · filed 2025-03-27 | -$75.55M derived: sum of 3 quarters · filed 2025-03-27 | -$103.70M 10-K · filed 2025-03-27 | |||||||||
| 2023-09-30 | -$22.69M 10-Q · filed 2024-11-07 | -$48.72M derived: sum of 2 quarters · filed 2024-11-07 | -$76.87M 10-Q · filed 2024-11-07 | -$115.58M derived: sum of 4 quarters · filed 2024-11-07 | |||||||||
| 2023-06-30 | -$26.03M 10-Q · filed 2024-08-07 | -$54.18M 10-Q · filed 2024-08-07 | -$92.88M derived: sum of 3 quarters · filed 2024-08-07 | -$131.62M derived: sum of 4 quarters · filed 2024-08-07 | |||||||||
| 2023-03-31 | -$28.15M 10-Q · filed 2024-05-08 | -$66.86M derived: sum of 2 quarters · filed 2024-05-08 | -$105.59M derived: sum of 3 quarters · filed 2024-05-08 | -$151.11M derived: sum of 4 quarters · filed 2024-05-08 | |||||||||
| 2022-12-31 | -$38.70M derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-19 | -$77.44M derived: sum of 2 quarters · filed 2024-03-19 | -$122.95M derived: sum of 3 quarters · filed 2024-03-19 | -$161.25M 10-K · filed 2024-03-19 | |||||||||
| 2022-09-30 | -$38.74M 10-Q · filed 2023-11-08 | -$84.25M derived: sum of 2 quarters · filed 2023-11-08 | -$122.55M 10-Q · filed 2023-11-08 | -$156.73M derived: sum of 4 quarters · filed 2023-11-08 | |||||||||
| 2022-06-30 | -$45.51M 10-Q · filed 2023-08-08 | -$83.81M 10-Q · filed 2023-08-08 | -$117.99M derived: sum of 3 quarters · filed 2023-08-08 | -$160.65M derived: sum of 4 quarters · filed 2023-08-08 | |||||||||
| 2022-03-31 | -$38.30M 10-Q · filed 2022-05-05 | -$72.48M derived: sum of 2 quarters · filed 2023-03-23 | -$115.13M derived: sum of 3 quarters · filed 2023-03-23 | -$141.60M derived: sum of 4 quarters · filed 2023-03-23 | |||||||||
| 2021-12-31 | -$34.18M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-23 | -$76.84M derived: sum of 2 quarters · filed 2023-03-23 | -$103.30M derived: sum of 3 quarters · filed 2023-03-23 | -$125.70M 10-K · filed 2023-03-23 | |||||||||
| 2021-09-30 | -$42.65M 10-Q · filed 2022-11-10 | -$69.12M derived: sum of 2 quarters · filed 2022-11-10 | -$91.52M 10-Q · filed 2022-11-10 | -$112.44M derived: sum of 4 quarters · filed 2022-11-10 | |||||||||
| 2021-06-30 | -$26.46M 10-Q · filed 2022-08-11 | -$48.87M 10-Q · filed 2022-08-11 | -$69.79M derived: sum of 3 quarters · filed 2022-08-11 | -$86.97M derived: sum of 4 quarters · filed 2022-08-11 | |||||||||
| 2021-03-31 | -$22.41M 10-Q · filed 2022-05-05 | -$43.33M derived: sum of 2 quarters · filed 2022-05-05 | -$60.51M derived: sum of 3 quarters · filed 2022-05-05 | -$73.27M derived: sum of 4 quarters · filed 2022-05-05 | |||||||||
| 2020-12-31 | -$20.92M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-25 | -$38.11M derived: sum of 2 quarters · filed 2022-03-25 | -$50.86M derived: sum of 3 quarters · filed 2022-03-25 | -$60.84M 10-K · filed 2022-03-25 | |||||||||
| 2020-09-30 | -$17.18M 10-Q · filed 2021-11-12 | -$29.94M derived: sum of 2 quarters · filed 2021-11-12 | -$39.92M 10-Q · filed 2021-11-12 | -$44.48M derived: sum of 4 quarters · filed 2021-11-12 | |||||||||
| 2020-06-30 | -$12.76M 10-Q · filed 2021-08-10 | -$22.73M 10-Q · filed 2021-08-10 | -$27.30M derived: sum of 3 quarters · filed 2021-08-10 | -$31.00M derived: sum of 4 quarters · filed 2021-08-10 | |||||||||
| 2020-03-31 | -$9.97M 10-Q · filed 2021-05-12 | -$14.54M derived: sum of 2 quarters · filed 2021-05-12 | -$18.25M derived: sum of 3 quarters · filed 2021-05-12 | -$22.38M derived: sum of 4 quarters · filed 2021-05-12 | |||||||||
| 2019-12-31 | -$4.56M derived: 10-K 6 month − 10-Q 3 month · filed 2021-03-24 | -$8.27M 10-K · filed 2021-03-24 | -$12.41M derived: sum of 3 quarters · filed 2021-03-24 | -$15.11M 10-K · filed 2021-03-24 | |||||||||
| 2019-09-30 | -$3.71M 10-Q · filed 2020-11-12 | -$7.84M derived: sum of 2 quarters · filed 2020-11-12 | -$10.55M 10-Q · filed 2020-11-12 | -$14.02M derived: sum of 4 quarters · filed 2020-11-12 | |||||||||
| 2019-06-30 | -$4.14M 10-Q · filed 2020-08-12 | -$6.84M 10-Q · filed 2020-08-12 | -$10.32M derived: sum of 3 quarters · filed 2020-08-12 | -$12.73M 10-K · filed 2021-03-24 | |||||||||
| 2019-03-31 | -$2.70M 10-Q · filed 2020-05-15 | -$6.18M derived: sum of 2 quarters · filed 2020-05-15 | -$8.59M 10-Q · filed 2019-05-15 | -$10.52M derived: sum of 4 quarters · filed 2020-05-15 | |||||||||
| 2018-12-31 | -$3.48M 10-Q · filed 2019-02-13 | -$5.89M 10-KT · filed 2020-03-26 | -$7.82M derived: sum of 3 quarters · filed 2020-03-26 | -$10.37M derived: sum of 4 quarters · filed 2020-03-26 | |||||||||
| 2018-09-30 | -$2.41M 10-Q · filed 2019-11-13 | -$4.34M derived: sum of 2 quarters · filed 2020-03-26 | -$6.89M derived: sum of 3 quarters · filed 2020-03-26 | -$8.35M derived: sum of 4 quarters · filed 2020-03-26 | |||||||||
| 2018-06-30 | -$1.93M derived: 10-KT 12 month − 10-Q 9 month · filed 2020-03-26 | -$4.48M derived: sum of 2 quarters · filed 2020-03-26 | -$5.94M derived: sum of 3 quarters · filed 2020-03-26 | -$6.92M 10-KT · filed 2020-03-26 | |||||||||
| 2018-03-31 | -$2.55M 10-Q · filed 2019-05-15 | -$4.01M derived: sum of 2 quarters · filed 2019-05-15 | -$4.99M 10-Q · filed 2019-05-15 | -$6.77M derived: sum of 4 quarters · filed 2019-05-15 | |||||||||
| 2017-12-31 | -$1.46M 10-Q · filed 2019-02-13 | -$2.44M 10-Q · filed 2019-02-13 | -$4.22M derived: sum of 3 quarters · filed 2019-02-13 | -$6.50M derived: sum of 4 quarters · filed 2019-02-13 | |||||||||
| 2017-09-30 | -$980.86K 10-Q · filed 2018-11-13 | -$2.76M derived: sum of 2 quarters · filed 2018-11-13 | -$5.05M derived: sum of 3 quarters · filed 2018-11-13 | -$6.58M derived: sum of 4 quarters · filed 2018-11-13 | |||||||||
| 2017-06-30 | -$1.78M derived: 10-K 12 month − 10-Q 9 month · filed 2018-09-28 | -$4.07M derived: sum of 2 quarters · filed 2018-09-28 | -$5.60M derived: sum of 3 quarters · filed 2018-09-28 | -$7.22M 10-K · filed 2018-09-28 | |||||||||
| 2017-03-31 | -$2.28M 10-Q · filed 2018-05-14 | -$3.82M derived: sum of 2 quarters · filed 2018-05-14 | -$5.44M 10-Q · filed 2018-05-14 | -$8.54M derived: sum of 4 quarters · filed 2018-05-14 | |||||||||
| 2016-12-31 | -$1.54M 10-Q · filed 2018-02-12 | -$3.15M 10-Q · filed 2018-02-12 | -$6.26M derived: sum of 3 quarters · filed 2018-02-12 | -$9.00M derived: sum of 4 quarters · filed 2018-02-12 | |||||||||
| 2016-09-30 | -$1.62M 10-Q · filed 2017-11-14 | -$4.72M derived: sum of 2 quarters · filed 2017-11-14 | -$7.47M derived: sum of 3 quarters · filed 2017-11-14 | -$13.19M derived: sum of 4 quarters · filed 2017-11-14 | |||||||||
| 2016-06-30 | -$3.10M derived: 10-K 12 month − 10-Q 9 month · filed 2017-09-28 | -$5.85M derived: sum of 2 quarters · filed 2017-09-28 | -$11.57M derived: sum of 3 quarters · filed 2017-09-28 | -$16.22M 10-K · filed 2017-09-28 | |||||||||
| 2016-03-31 | -$2.75M 10-Q · filed 2017-05-15 | -$8.47M derived: sum of 2 quarters · filed 2017-05-15 | -$13.11M 10-Q · filed 2017-05-15 | -$17.50M derived: sum of 4 quarters · filed 2017-05-15 | |||||||||
| 2015-12-31 | -$5.72M 10-Q · filed 2017-02-10 | -$10.35M 10-Q · filed 2017-02-10 | -$14.75M derived: sum of 3 quarters · filed 2017-02-10 | -$19.33M derived: sum of 4 quarters · filed 2017-02-10 | |||||||||
| 2015-09-30 | -$4.63M 10-Q · filed 2016-11-10 | -$9.03M derived: sum of 2 quarters · filed 2016-11-10 | -$13.61M derived: sum of 3 quarters · filed 2016-11-10 | -$18.00M derived: sum of 4 quarters · filed 2016-11-10 | |||||||||
| 2015-06-30 | -$4.40M derived: 10-K 12 month − 10-Q 9 month · filed 2016-09-09 | -$8.98M derived: sum of 2 quarters · filed 2016-09-09 | -$13.37M derived: sum of 3 quarters · filed 2016-09-09 | -$17.10M 10-K · filed 2016-09-09 | |||||||||
| 2015-03-31 | -$4.58M 10-Q · filed 2016-05-09 | -$4.57M 10-Q · filed 2015-05-15 | -$8.96M derived: sum of 2 quarters · filed 2016-05-09 | -$12.70M 10-Q · filed 2016-05-09 | -$12.68M 10-Q · filed 2015-05-15 | -$24.92M derived: sum of 4 quarters · filed 2016-05-09 | |||||||
| 2014-12-31 | -$4.38M 10-Q · filed 2016-02-05 | -$8.11M 10-Q · filed 2016-02-05 | -$20.34M derived: sum of 3 quarters · filed 2016-02-05 | -$21.05M derived: sum of 4 quarters · filed 2016-02-05 | |||||||||
| 2014-09-30 | -$3.72M 10-Q · filed 2015-11-06 | -$15.96M derived: sum of 2 quarters · filed 2015-11-06 | -$16.67M derived: sum of 3 quarters · filed 2015-11-06 | ||||||||||
| 2014-06-30 | -$12.23M derived: 10-K 6 month − 10-Q 3 month · filed 2015-09-11 | -$12.95M 10-K · filed 2015-09-11 | |||||||||||
| 2014-03-31 | -$711.90K 10-Q · filed 2015-05-15 | -$6.25M 10-Q · filed 2015-05-15 | -$17.11M 8-K · filed 2014-05-27 | ||||||||||
| 2014-02-28 | -$3.12K 10-Q · filed 2014-04-15 | -$17.50K 10-Q · filed 2014-04-15 | -$74.66K 10-Q · filed 2014-04-15 | ||||||||||
| 2013-12-31 | -$5.06M 10-Q · filed 2015-02-13 | -$5.54M 10-Q · filed 2015-02-13 | -$6.77M 10-K · filed 2015-09-11 | -$16.40M 8-K · filed 2014-05-27 | |||||||||
| 2013-11-30 | -$14.37K 10-Q · filed 2014-01-13 | -$71.53K 10-Q · filed 2014-01-13 | |||||||||||
| 2013-09-30 | -$481.84K 10-Q · filed 2014-11-07 | ||||||||||||
| 2013-08-31 | -$12.36K derived: 10-K 12 month − 10-Q 9 month · filed 2013-12-16 | -$31.85K derived: sum of 2 quarters · filed 2013-12-16 | -$45.02K 10-K · filed 2013-12-16 | -$57.16K 10-K · filed 2013-12-16 | |||||||||
| 2013-05-31 | -$19.48K 10-Q · filed 2013-07-12 | -$32.65K 10-Q · filed 2013-07-12 | -$44.79K 10-Q · filed 2013-07-12 | ||||||||||
| 2013-03-31 | -$600.92K 8-K · filed 2014-05-27 | ||||||||||||
| 2013-02-28 | -$4.15K 10-Q · filed 2014-04-15 | -$13.17K 10-Q · filed 2014-04-15 | -$21.80K derived: sum of 3 quarters · filed 2014-04-15 | -$24.28K derived: sum of 4 quarters · filed 2014-04-15 | -$25.31K 10-Q · filed 2013-05-03 | ||||||||
| 2012-12-31 | -$3.16M 10-KT · filed 2014-09-09 | ||||||||||||
| 2012-11-30 | -$9.02K 10-Q · filed 2014-01-13 | -$17.65K derived: sum of 2 quarters · filed 2014-01-13 | -$20.13K derived: sum of 3 quarters · filed 2014-01-13 | -$20.63K derived: sum of 4 quarters · filed 2014-01-13 | |||||||||
| 2012-08-31 | -$8.63K derived: 10-K 12 month − 10-Q 9 month · filed 2013-12-16 | -$11.11K derived: sum of 2 quarters · filed 2013-12-16 | -$11.61K derived: sum of 3 quarters · filed 2013-12-16 | -$12.05K 10-K · filed 2013-12-16 | |||||||||
| 2012-05-31 | -$2.48K 10-Q · filed 2013-07-12 | -$2.98K derived: sum of 2 quarters · filed 2013-07-12 | -$3.42K 10-Q · filed 2013-07-12 | ||||||||||
| 2012-02-29 | -$503.00 10-Q · filed 2013-05-03 | -$942.00 10-Q · filed 2013-05-03 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Opus Genetics, Inc. (IRD) | United States | $0.406B | -3.16 |
| Arcturus Therapeutics Holdings Inc. (ARCT) | $0.402B | -2.05 | |
| GALECTIN THERAPEUTICS INC (GALT) | United States | $0.399B | -11.06 |
| ARS Pharmaceuticals, Inc. (SPRY) | United States | $0.414B | -3.70 |
| Atea Pharmaceuticals, Inc. (AVIR) | United States | $0.414B | -2.26 |
| Turn Therapeutics Inc. (TTRX) | United States | $0.397B | -25.68 |
| DiaMedica Therapeutics Inc. (DMAC) | United States | $0.423B | -10.11 |
| PROTHENA CORP PUBLIC LTD CO (PRTA) | Ireland | $0.428B | -11.53 |
| Rezolute, Inc. (RZLT) | United States | $0.382B | -6.45 |
| CYPHERPUNK TECHNOLOGIES INC. (CYPH) | United States | $0.438B | -75.63 |